Cancer, checkpoint inhibitors, and confusion
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F17%3A10367071" target="_blank" >RIV/00216208:11310/17:10367071 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/S1470-2045(17)30810-0" target="_blank" >http://dx.doi.org/10.1016/S1470-2045(17)30810-0</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S1470-2045(17)30810-0" target="_blank" >10.1016/S1470-2045(17)30810-0</a>
Alternative languages
Result language
angličtina
Original language name
Cancer, checkpoint inhibitors, and confusion
Original language description
The premise of immunotherapy is that cancer is non-self and antigenic, and therefore is capable of eliciting an immune response. The absence of an immune response is attributed to evasion mechanisms. On the basis of the work of Tasuku Honjo (Kyoto University, Kyoto, Japan) and others, releasing the immune brakes and activation of T cells might be a logical way of treating cancer. However, the immune distinction between foreign and self is not absolute, and intervention can be misdirected.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10601 - Cell biology
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The Lancet: Oncology
ISSN
1470-2045
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
11
Country of publishing house
GB - UNITED KINGDOM
Number of pages
1
Pages from-to
"E632"
UT code for WoS article
000414134100011
EID of the result in the Scopus database
—